Rare diseases
Investigational molecules
Locations
Konstadinoupoleos 49, 546 42 Thessaloniki, Greece
Hippokration Hospital in Thessaloniki, Greece specialises in clinical trials of conditions such as Chronic kidney disease, Type 2 diabetes mellitus, Metabolic dysfunction-associated steatohepatitis, Systemic lupus erythematosus, and other specialisations. This site conducts important research.
More sites in ThessalonikiGreece
Clinical trials currently enrolling participants at this site.
Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
GreeceStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
GreeceStudy of Elafibranor for Adults with Primary Biliary Cholangitis
GreeceProphylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)
GreeceA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
GreeceA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
GreeceSafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
GreeceA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
GreeceA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
GreeceA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
GreeceA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
GreeceA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
GreeceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
